Company Filing History:
Years Active: 2019-2020
Title: Innovations of Inventor Xiao-Long Qiu
Introduction
Xiao-Long Qiu, a distinguished inventor based in Haimen, China, has made significant contributions to the field of cancer research. With a portfolio of 2 patents, his work focuses on developing novel compounds that have the potential to improve treatment options for cancer patients.
Latest Patents
Among his notable inventions, two patents stand out: both pertain to RAD51 inhibitors. The first patent details the compounds and their application in preventing or treating cancer. The invention emphasizes the significance of these RAD51 inhibitors in enabling targeted treatment options. The second patent reiterates the innovative approach introduced in the first, further showcasing the potential of these compounds to help subjects in need of effective cancer treatment. The methods highlighted in both patents involve the administration of a therapeutically effective amount of the compounds to the patients.
Career Highlights
Xiao-Long Qiu is affiliated with the University of California, where his research and development efforts significantly contribute to advancements in medicine. His focus on RAD51 inhibitors reflects a commitment to addressing critical challenges in oncology.
Collaborations
In his professional journey, Xiao-Long Qiu collaborates with esteemed colleagues, including Jiewen Zhu and Wen-Hwa Lee. These partnerships enhance the innovative research environment and contribute to the development of effective cancer treatment strategies.
Conclusion
Xiao-Long Qiu exemplifies the role of an inventive mind in advancing cancer treatment through innovative solutions. His notable patents and collaborative efforts hold promise for the future of oncology, offering hope to patients worldwide.